Scientists create a 'Lipid Library' to unlock secrets of rare cholesterol conditions
NCT ID NCT04156997
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a collection of blood samples and health information from 250 adults with very high or very low cholesterol or related lipid problems. Researchers will analyze these samples to learn more about the genetic and biological causes of these extreme lipid disorders. The goal is to better understand these conditions, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 250 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2019
- Expected to finish
-
May 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects with lipid and metabolism disorders and up to 50 healthy volunteers (age 18 years or older) with a normal lipid metabolism.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * adult patients (age 18 years or older) diagnosed with any lipid or metabolic disorder including hyperlipidemia, dyslipidemia, hyperlipoproteinemia, low HDL levels and deranged lipoprotein metabolism Exclusion Criteria: * Anyone under 18 years of age will be excluded from the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dyslipidemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Parkland Health Hospital System
Dallas, Texas, 75390, United States
-
University of Texas Southwestern Medical Center - Ambulatory Clinic
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smoking and diet may shape cholesterol in mexican adults
- Triple-Drug cholesterol attack aims to strike within 72 hours of a heart attack
- New pill aims to lower 'Bad' cholesterol: first human test begins
- Vitamin B3 supplement put to the test against psoriasis inflammation
- Can cottonseed oil improve cholesterol? trial tests common cooking oil against similar blends
- Can big data unmask hidden clusters of cardiometabolic disease?